P

Assignee

ABGENIX INC

US31 patents

Top patents by PatentIndex Score

US7338660B2Mar 4, 2008

Methods of treating cancer and enhancing immune responses with antibodies that bind CD40

ABGENIX INC144 citations99
US6673986B1Jan 6, 2004

Generation of xenogeneic antibodies

ABGENIX INC478 citations99
US6657103B1Dec 2, 2003

Human antibodies derived from immunized xenomice

ABGENIX INC260 citations99
US6458592B1Oct 1, 2002

Production of antibodies using cre-mediated site-specific recombination

ABGENIX INC126 citations99
US6235883B1May 22, 2001

Human monoclonal antibodies to epidermal growth factor receptor

ABGENIX INC831 citations99
US6162963ADec 19, 2000

Generation of Xenogenetic antibodies

ABGENIX INC1,334 citations99
US6150584ANov 21, 2000

Human antibodies derived from immunized xenomice

ABGENIX INC3,069 citations99
US6130364AOct 10, 2000

Production of antibodies using Cre-mediated site-specific recombination

ABGENIX INC521 citations99
US6091001AJul 18, 2000

Production of antibodies using Cre-mediated site-specific recombination

ABGENIX INC502 citations99
US6075181AJun 13, 2000

Human antibodies derived from immunized xenomice

ABGENIX INC3,137 citations99
US5939598AAug 17, 1999

Method of making transgenic mice lacking endogenous heavy chains

ABGENIX INC2,618 citations99
US7563442B2Jul 21, 2009

Antibodies to CD40 and methods of treating cancer and enhancing immune responses

ABGENIX INC62 citations98
US7049426B2May 23, 2006

Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions

ABGENIX INC162 citations98
US6833268B1Dec 21, 2004

Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions

ABGENIX INC211 citations98
US6682736B1Jan 27, 2004

Human monoclonal antibodies to CTLA-4

ABGENIX INC776 citations98
US5985615ANov 16, 1999

Directed switch-mediated DNA recombination

ABGENIX INC346 citations98
US5916771AJun 29, 1999

Production of a multimeric protein by cell fusion method

ABGENIX INC1,034 citations98
US7064244B2Jun 20, 2006

Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom

ABGENIX INC197 citations97
US6207418B1Mar 27, 2001

Production of a multimeric protein by cell fusion method

ABGENIX INC86 citations97
US6114598ASep 5, 2000

Generation of xenogeneic antibodies

ABGENIX INC1,486 citations97
US7202343B2Apr 10, 2007

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof

ABGENIX INC78 citations96
US6924360B2Aug 2, 2005

Antibodies against the MUC18 antigen

ABGENIX INC79 citations96
US6420140B1Jul 16, 2002

Production of multimeric protein by cell fusion method

ABGENIX INC122 citations96
US7067131B2Jun 27, 2006

Methods for using anti-MUC18 antibodies

ABGENIX INC61 citations95
US7141653B2Nov 28, 2006

Human monoclonal antibodies to interleukin-5

ABGENIX INC59 citations93
US7078492B2Jul 18, 2006

Human antipneumococcal antibodies from non-human animals

ABGENIX INC65 citations92
US5998209ADec 7, 1999

Generation of large genomic DNA deletions

ABGENIX INC344 citations92
US7090844B2Aug 15, 2006

Use of antibodies against the MUC18 antigen

ABGENIX INC48 citations91
US6677138B2Jan 13, 2004

Production of a multimeric protein by cell fusion method

ABGENIX INC8 citations73
US6395515B1May 28, 2002

Directed switch-mediated DNA recombination

ABGENIX INC2 citations61
US6884622B1Apr 26, 2005

Method for preparing a mammalian cell deficient in HPRT

ABGENIX INC0 citations45